Phase I trial of combined chemotherapy of bevacizumab, panitumumab and irinotecan as 3rd-line chemotherapy in chmotherapy-refractory metastatic colorectal cancer.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Biomarker
- 21 Dec 2012 New trial record